Anthropic has not yet sold a single share to the public, but Wall Street is already building a cottage industry around its stock. More than 20 exchange-traded products have been filed to deliver leveraged — and in some cases inverse — exposure to the artificial-intelligence company's daily share moves, according to providers and filings tracked across Bloomberg, Reuters-adjacent outlets and Asian business press, setting up one of the most crowded pre-IPO product races in recent memory.

The stampede is being led by Direxion, whose leveraged Anthropic ETFs are scheduled to begin trading Monday. ProShares and GraniteShares have also filed, while Leverage Shares by Themes has readied a suite of tickers — ANUU for 2x long exposure, ANDD and ANSS for leveraged and short strategies — ahead of the company's debut. GraniteShares' AIL and ANS products are likewise waiting in the queue, with ANS positioned as a 2x short vehicle.

A race that starts before the opening bell

The dynamic is unusual: the underlying security does not yet exist in public markets, yet issuers are jostling for shelf space and first-mover branding. Direxion global ETF strategist Bilal Little, appearing on a special edition of Bloomberg Markets with Scarlet Fu, framed the launches as part of a land grab in which providers are competing to be first to market with amplified exposure on both the long and short side.

Direxion's Bilal Little told Bloomberg's Scarlet Fu that providers are jostling for a first-mover advantage as firms race to list products that amplify Anthropic's daily moves in both directions.

The lineup reflects how the $10-trillion-plus U.S. ETF complex has industrialized the "single-stock leveraged" template pioneered during the meme-stock era and refined through the Tesla, Nvidia and, more recently, SpaceX episodes. Each new high-profile listing now arrives with a pre-built derivatives ecosystem attached.

The $81 billion payday — and the lockup problem

Behind the product filings sits a far larger event: an offering valued at roughly $81 billion, a figure that would make Anthropic one of the largest technology listings in history and a transformative payout for early employees and investors. Anthropic has filed its S-1 with regulators, formally kicking off the process even as the ETF issuers finalize their own paperwork.

But the windfall comes with friction. Reports note that employees face an unusual hurdle before they can convert paper wealth into cash — a restriction layered on top of the customary post-IPO lockup period that typically bars insiders from selling for 180 days. The practical effect is to concentrate any early selling pressure among a narrow set of pre-existing shareholders and to complicate the arithmetic for funds that hold private Anthropic shares and must mark them to an as-yet-undetermined public price.

Pre-IPO access and the "SpaceX déjà vu"

For retail investors unwilling to wait, the market already offers indirect routes. Vehicles such as Tema ETFs' pre-IPO exposure funds, along with interval funds and tender-offer vehicles, have been assembling stakes in late-stage private AI companies. Data provider flows show such funds drawing steady inflows as Anthropic's profile has risen — a pattern Seeking Alpha likened to the "SpaceX déjà vu," when demand for pre-IPO exposure to Elon Musk's rocket company drove money into secondary-access vehicles long before any listing.

Tema's chief executive has publicly discussed both the appeal of pre-IPO AI exposure and the capital risks it entails, including valuation opacity, illiquidity and the possibility that the eventual public price disappoints relative to the private marks embedded in fund NAVs.

Tokenization enters the conversation

The listing is also being read through a second lens: the race to tokenize real-world assets. Forbes framed Anthropic's IPO as a case study in how quickly tokenized-equity and on-chain wrappers could attach themselves to a marquee listing, raising familiar questions about custody, regulatory jurisdiction and whether synthetic exposure is a feature or a hazard for ordinary investors.

What investors should weigh

  • Daily-reset mechanics: leveraged and inverse ETFs rebalance each day, so returns diverge sharply from longer-horizon performance in volatile markets — a well-documented "decay" effect.
  • Launch-day liquidity: newly listed single-stock products often trade wide spreads until assets accumulate, and issuer closures have historically hit niche funds.
  • Underlying supply: if insider lockups and employee selling restrictions limit float, both the stock and the ETFs tracking it could see amplified volatility.
  • Regulatory scrutiny: U.S. and Asian regulators have signaled interest in single-stock leveraged products generally, and the pace of filings — noted by Korea's Asia Business Daily as exceeding 20 products — may invite closer review.

The bigger picture

Whatever the short-term trading dynamics, the frenzy illustrates how financial engineering now runs ahead of primary markets. A company's IPO once marked the moment public investors could participate; today, issuers, index providers and derivatives desks construct the wrappers first and let the offering catch up. For Anthropic — a company whose own messaging emphasizes safety and caution — the spectacle of 2x long and 2x short tickers racing to market ahead of its shares is an ironic debut, and a test of whether regulators, issuers and investors can keep the plumbing in step with the hype.